Analyst Offers Insight on Favorable FDA Ruling for Teva Pharma By: Benzinga via Benzinga March 31, 2014 at 16:03 PM EDT Shares of Teva Pharmaceutical (NYSE: TEVA) are up 6.66 percent to $52.74 on news that the company has received a U.S. Supreme Court ... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR